Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BX002-A in Healthy Adults
NCT04737876Phase 1Completed
- Sponsor
- BiomX
- Start
- Oct 2020
- Primary completion
- Dec 2020
- Modality
- Single Strain Products, Multi-strain Products
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in inflammatory bowel disease (IBD) and Primary Sclerosing Cholangitis (PSC) comparing BX002-A with Placebo (2 arms). Primary endpoint: Adverse Events at Day 31. Started Oct 2020; status: completed.
02
Drugs
BX002-A
03
Conditions
inflammatory bowel disease (IBD)Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT04737876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04737876.